Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy.
Quick navigation
Link to full study
http://www.ncbi.nlm.nih.gov/pubmed/22085343
Conclusion of this study
Among patients with atherosclerotic cardiovascular disease and LDL cholesterol levels of less than 70 mg per deciliter (1.81 mmol per liter), there was no incremental clinical benefit from the addition of niacin to statin therapy during a 36-month follow-up period, despite significant improvements in HDL cholesterol and triglyceride levels. (Funded by the National Heart, Lung, and Blood Institute and Abbott Laboratories; AIM-HIGH ClinicalTrials.gov number, NCT00120289.).
Supplements analyzed in this study
Health conditions analyzed in this study
Functions related to this study
Body systems related to this study